The ph2 trial is 22 weeks long. A oh 3 would need
Post# of 144497
![](/assets/46931549/no_avatar_available_thumb.jpg)
I think most likely a ph 3 would be required, but there are growing thoughts that the more indications we get approved, and the more safety data we compile, the more likely we get approvals after ph 2
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)